Dr. McMahon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1665 Aurora Ct
Aurora, CO 80045Phone+1 720-848-0000
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2018
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2012 - 2015
- Duke University School of MedicineClass of 2012
Certifications & Licensure
- CO State Medical License 2020 - 2025
- WY State Medical License 2021 - 2025
- PA State Medical License 2012 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 5 citationsMenin Inhibition With Revumenib for-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).Ghayas C Issa, Ibrahim Aldoss, Michael J Thirman, John DiPersio, Martha Arellano
Journal of Clinical Oncology. 2025-01-01 - Response to intensive induction chemotherapy after failure of frontline azacitidine and venetoclax in acute myeloid leukemia.Kellen B Gil, Diana Abbott, Maria L Amaya, Marc Schwartz, Jonathan A Gutman
Leukemia & Lymphoma. 2024-12-01 - Outcomes of Haplo-Cord Versus Dual Cord Transplants: A Single-Center Retrospective Analysis.Andrew Kent, Kellen B Gil, Michael K Jones, Brooke Linden, Enkhee Purev
Transplantation and Cellular Therapy. 2024-08-17
Lectures
- Longitudinal Monitoring of AML Tumors with High-Throughput Single-Cell DNA Sequencing Reveals Rare Clones Prognostic for Disease Progression and Therapy Response2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Impact of Leukapheresis and Time to Chemotherapy on Outcomes of Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Presenting with Hyperleukocytosis: An ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: